应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01228 北海康成-B
休市中 02-06 16:08:02
3.090
-0.060
-1.90%
最高
3.270
最低
2.960
成交量
927.90万
今开
3.150
昨收
3.150
日振幅
9.84%
总市值
15.79亿
流通市值
15.79亿
总股本
5.11亿
成交额
2,906万
换手率
1.82%
流通股本
5.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
北海康成-B盘中异动 股价大跌5.08%
市场透视 · 02-06 15:16
北海康成-B盘中异动 股价大跌5.08%
北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股
公告速递 · 02-05
北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股
北海康成-B盘中异动 股价大涨5.24%
市场透视 · 02-04
北海康成-B盘中异动 股价大涨5.24%
北海康成-B02月02日主力净流出65.9万元 散户资金买入
市场透视 · 02-02
北海康成-B02月02日主力净流出65.9万元 散户资金买入
北海康成-B01月29日主力净流出114.3万元 散户资金买入
市场透视 · 01-29
北海康成-B01月29日主力净流出114.3万元 散户资金买入
北海康成-B01月28日获主力加仓28.9万元
市场透视 · 01-28
北海康成-B01月28日获主力加仓28.9万元
北海康成-B盘中异动 快速上涨5.63%报2.440港元
市场透视 · 01-26
北海康成-B盘中异动 快速上涨5.63%报2.440港元
北海康成-B盘中异动 临近收盘股价大涨5.36%报2.360港元
市场透视 · 01-23
北海康成-B盘中异动 临近收盘股价大涨5.36%报2.360港元
北海康成-B盘中异动 下午盘股价大涨7.17%报2.390港元
市场透视 · 01-22
北海康成-B盘中异动 下午盘股价大涨7.17%报2.390港元
北海康成-B盘中异动 急速拉升7.66%报2.390港元
市场透视 · 01-16
北海康成-B盘中异动 急速拉升7.66%报2.390港元
北海康成-B(01228)授出合共约637.26万份购股权及637.26万份受限制股份单位
智通财经 · 01-12
北海康成-B(01228)授出合共约637.26万份购股权及637.26万份受限制股份单位
北海康成(1228)更新12月股份变动月报表,股本增加至约5.11亿股
公告速递 · 01-07
北海康成(1228)更新12月股份变动月报表,股本增加至约5.11亿股
北海康成-B盘中异动 股价大跌5.08%报2.240港元
市场透视 · 01-05
北海康成-B盘中异动 股价大跌5.08%报2.240港元
385只港股2025年涨幅超100% “红底股”显著增加
财经网 · 01-05
385只港股2025年涨幅超100% “红底股”显著增加
北海康成-B盘中异动 急速下挫5.68%
市场透视 · 2025-12-29
北海康成-B盘中异动 急速下挫5.68%
北海康成-B12月23日获主力加仓63.8万元
市场透视 · 2025-12-23
北海康成-B12月23日获主力加仓63.8万元
北海康成-B盘中异动 早盘股价大跌5.34%报1.950港元
市场透视 · 2025-12-18
北海康成-B盘中异动 早盘股价大跌5.34%报1.950港元
北海康成-B12月16日主力净流出31万元 散户资金买入
市场透视 · 2025-12-16
北海康成-B12月16日主力净流出31万元 散户资金买入
北海康成-B(01228)自主研发生产的CAN 103获纳入中国第一版“商保创新药目录”
智通财经 · 2025-12-08
北海康成-B(01228)自主研发生产的CAN 103获纳入中国第一版“商保创新药目录”
北海康成-B12月08日主力净流出147.7万元 散户资金买入
市场透视 · 2025-12-08
北海康成-B12月08日主力净流出147.7万元 散户资金买入
加载更多
公司概况
公司名称:
北海康成-B
所属市场:
SEHK
上市日期:
--
主营业务:
CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合,其中包括三种获批药物和八种资产的管线,针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法,用于治疗II型粘多糖贮积症(MPS II),也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂,正在开发中,用于治疗罕见的胆汁淤积性肝病,包括Alagille综合征和进行性家族性肝内胆汁淤积症。
发行价格:
--
{"stockData":{"symbol":"01228","market":"HK","secType":"STK","nameCN":"北海康成-B","latestPrice":3.09,"timestamp":1770365282430,"preClose":3.15,"halted":0,"volume":9279000,"delay":0,"changeRate":-0.019047619047619067,"floatShares":511000000,"shares":511000000,"eps":-1.041874,"marketStatus":"休市中","change":-0.06,"latestTime":"02-06 16:08:02","open":3.15,"high":3.27,"low":2.96,"amount":29058290,"amplitude":0.098413,"askPrice":3.09,"askSize":63000,"bidPrice":3.01,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-0.292,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":3.15,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":1.2101712289845847,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01228","defaultTab":"news","newsList":[{"id":"2609514854","title":"北海康成-B盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609514854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609514854?lang=zh_cn&edition=full","pubTime":"2026-02-06 15:16","pubTimestamp":1770362184,"startTime":"0","endTime":"0","summary":"2026年02月06日下午盘15时16分,北海康成-B股票出现波动,股价急速下跌5.08%。截至发稿,该股报2.990港元/股,成交量780.2万股,换手率1.53%,振幅8.89%。资金方面,该股资金流入1486.12万港元,流出783.703万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体跌幅为0.12%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020615162497a52855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020615162497a52855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"1131459471","title":"北海康成(01228)更新2026年1月股份变动月报表,期权行使增发102,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1131459471","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131459471?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:38","pubTimestamp":1770284319,"startTime":"0","endTime":"0","summary":"北海康成製藥有限公司于2026年2月5日发布2026年1月股份变动月报表。报告期覆盖2026年1月1日至1月31日。已发行股份由期初的511,120,234股增至期末的511,222,234股,本月内新增发行为102,000股,主要来源于首次公开发售后购股权计划的行使。根据公告,本月在行使期权方面,股东大会曾于2024年6月27日批准的购股权计划产生102,000股新股发行。公司确认截至2026年1月31日已符合香港联交所的最低公众持股量要求,股权结构保持畅通。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2608033126","title":"北海康成-B盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608033126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608033126?lang=zh_cn&edition=full","pubTime":"2026-02-04 11:14","pubTimestamp":1770174893,"startTime":"0","endTime":"0","summary":"2026年02月04日早盘11时14分,北海康成-B股票出现异动,股价快速拉升5.24%。截至发稿,该股报2.810港元/股,成交量403.955万股,换手率0.79%,振幅4.12%。北海康成-B股票所在的生物技术行业中,整体跌幅为0.79%。其相关个股中,帝王国际投资、轩竹生物-B、北海康成-B涨幅较大,振幅较大的相关个股有帝王国际投资、圣诺医药-B、奥星生命科技,振幅分别为18.02%、11.93%、11.90%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204111453a6d0ebfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204111453a6d0ebfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2608813783","title":"北海康成-B02月02日主力净流出65.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2608813783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608813783?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:15","pubTimestamp":1770020146,"startTime":"0","endTime":"0","summary":"02月02日, 北海康成-B股价跌3.24%,报收2.69元,成交金额502.4万元,换手率0.36%,振幅4.32%,量比0.28。北海康成-B今日主力资金净流出65.9万元,上一交易日主力净流入73.3万元。该股近5个交易日下跌1.10%,主力资金累计净流出45.6万元;近20日主力资金累计净流入461.7万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162056a4727d04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162056a4727d04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2607087558","title":"北海康成-B01月29日主力净流出114.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607087558?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:16","pubTimestamp":1769674570,"startTime":"0","endTime":"0","summary":"01月29日, 北海康成-B股价跌4.98%,报收2.67元,成交金额1051.1万元,换手率0.74%,振幅9.96%,量比0.75。北海康成-B今日主力资金净流出114.3万元,上一交易日主力净流入28.9万元。该股近5个交易日上涨19.20%,主力资金累计净流入505.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入454.3万元,其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162743a6bad53b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162743a6bad53b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2606879902","title":"北海康成-B01月28日获主力加仓28.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606879902","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606879902?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:16","pubTimestamp":1769588169,"startTime":"0","endTime":"0","summary":"01月28日, 北海康成-B股价涨4.85%,报收2.81元,成交金额1920.5万元,换手率1.37%,振幅7.09%,量比1.79。北海康成-B今日主力资金净流入28.9万元,连续3日净流入,上一交易日主力净流入32.5万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为100.00%,平均涨幅为18.23%。该股近5个交易日上涨26.01%,主力资金累计净流入619.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入858.0万元,其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163008a45f7b4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128163008a45f7b4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2606421975","title":"北海康成-B盘中异动 快速上涨5.63%报2.440港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606421975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606421975?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:02","pubTimestamp":1769392950,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时02分,北海康成-B股票出现波动,股价快速拉升5.63%。截至发稿,该股报2.440港元/股,成交量43.4万股,换手率0.08%,振幅6.06%。资金方面,该股资金流入68.856万港元,流出25.878万港元。北海康成-B股票所在的生物技术行业中,整体跌幅为2.29%。其相关个股中,中生北控生物科技、维亚生物、康希诺生物涨幅较大,振幅较大的相关个股有中生北控生物科技、维亚生物、来凯医药-B,振幅分别为17.28%、15.35%、14.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126100230a4555e93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126100230a4555e93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2605575471","title":"北海康成-B盘中异动 临近收盘股价大涨5.36%报2.360港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605575471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605575471?lang=zh_cn&edition=full","pubTime":"2026-01-23 15:31","pubTimestamp":1769153502,"startTime":"0","endTime":"0","summary":"2026年01月23日临近收盘15时31分,北海康成-B股票出现异动,股价大幅拉升5.36%。截至发稿,该股报2.360港元/股,成交量156万股,换手率0.31%,振幅9.37%。资金方面,该股资金流入147.702万港元,流出171.021万港元。北海康成-B股票所在的生物技术行业中,整体涨幅为2.18%。其相关个股中,中生北控生物科技、维亚生物、来凯医药-B涨幅较大,振幅较大的相关个股有中生北控生物科技、帝王国际投资、百奥赛图-B,振幅分别为29.75%、27.37%、18.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123153142a44d5164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123153142a44d5164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2605146798","title":"北海康成-B盘中异动 下午盘股价大涨7.17%报2.390港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605146798?lang=zh_cn&edition=full","pubTime":"2026-01-22 13:00","pubTimestamp":1769058006,"startTime":"0","endTime":"0","summary":"2026年01月22日下午盘13时00分,北海康成-B股票出现波动,股价快速上涨7.17%。截至发稿,该股报2.390港元/股,成交量20.8万股,换手率0.04%,振幅8.52%。资金方面,该股资金流入17.547万港元,流出25.278万港元。北海康成-B股票所在的生物技术行业中,整体跌幅为1.37%。其相关个股中,药捷安康-B、科济药业-B、荃信生物-B涨幅较大,振幅较大的相关个股有中生北控生物科技、药捷安康-B、荃信生物-B,振幅分别为27.63%、14.75%、8.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122130006a44856a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122130006a44856a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2604916170","title":"北海康成-B盘中异动 急速拉升7.66%报2.390港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604916170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604916170?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:30","pubTimestamp":1768527008,"startTime":"0","endTime":"0","summary":"2026年01月16日早盘09时30分,北海康成-B股票出现异动,股价大幅上涨7.66%。截至发稿,该股报2.390港元/股,成交量1000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入2390港元,流出0港元。北海康成-B股票所在的生物技术行业中,整体跌幅为0.73%。其相关个股中,北海康成-B、东曜药业-B、银诺医药-B涨幅较大,振幅较大的相关个股有东曜药业-B、药明生物、再鼎医药,振幅分别为3.34%、2.15%、1.80%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116093008a4c9ab8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116093008a4c9ab8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2602834549","title":"北海康成-B(01228)授出合共约637.26万份购股权及637.26万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2602834549","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602834549?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:42","pubTimestamp":1768228951,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B(01228)公布,于2026年1月12日,公司根据首次公开发售后购股权计划向30名购股权承授人授出合共6,372,575份购股权及根据首次公开发售后受限制股份单位计划向28名受限制股份单位承授人授出合共6,372,575份受限制股份单位。授出的购股权的行使价为每股2.32港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"1132699867","title":"北海康成(1228)更新12月股份变动月报表,股本增加至约5.11亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132699867","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132699867?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:16","pubTimestamp":1767773797,"startTime":"0","endTime":"0","summary":"北海康成制药有限公司于2026年1月7日提交截至2025年12月31日的月报表。公告显示,该公司注册股本维持在5,000,000,000股,面值每股0.00001美元,总额不变为50,000美元。本报告期内,已发行股份由上月的510,826,484股增至511,120,234股,整体增加293,750股。报告期内并无股份购回或注销活动。截至2025年12月31日,北海康成制药有限公司股本总数增至511,120,234股。公司同时确认其遵守香港联交所上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01228"],"gpt_icon":0},{"id":"2601104074","title":"北海康成-B盘中异动 股价大跌5.08%报2.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601104074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601104074?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:15","pubTimestamp":1767579344,"startTime":"0","endTime":"0","summary":"2026年01月05日早盘10时15分,北海康成-B股票出现波动,股价大幅下跌5.08%。截至发稿,该股报2.240港元/股,成交量14.2万股,换手率0.03%,振幅3.39%。资金方面,该股资金流入3.928万港元,流出23.953万港元。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体涨幅为2.39%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010510154497a10203&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010510154497a10203&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2601076259","title":"385只港股2025年涨幅超100% “红底股”显著增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2601076259","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601076259?lang=zh_cn&edition=full","pubTime":"2026-01-05 00:00","pubTimestamp":1767542400,"startTime":"0","endTime":"0","summary":"刚刚过去的2025年,港股市场诞生了一批涨幅超10倍的牛股,“红底股”阵营持续扩大,业内多家机构继续看好2026年港股市场。另外,股价突破100港元的“红底股”阵营持续扩大,不少新增“红底股”为去年上市的新股,也成为港股市场流动性显著提升的重要体现。截至2025年12月31日收盘,港股“红底股”数量达45只,较2025年初的22只有显著增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095801a6f3bf3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105095801a6f3bf3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","03750","09678","09961","02097","09988","03690","BK1148","00388","08460","01815"],"gpt_icon":0},{"id":"2595876037","title":"北海康成-B盘中异动 急速下挫5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595876037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595876037?lang=zh_cn&edition=full","pubTime":"2025-12-29 10:17","pubTimestamp":1766974671,"startTime":"0","endTime":"0","summary":"2025年12月29日早盘10时17分,北海康成-B股票出现波动,股价大幅下挫5.68%。截至发稿,该股报2.160港元/股,成交量9.7万股,换手率0.02%,振幅4.37%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。北海康成-B股票所在的生物技术行业中,整体跌幅为0.81%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229101751a4840771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229101751a4840771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2593411866","title":"北海康成-B12月23日获主力加仓63.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593411866","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593411866?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477751,"startTime":"0","endTime":"0","summary":"12月23日, 北海康成-B股价涨3.70%,报收2.24元,成交金额558.3万元,换手率0.49%,振幅7.87%,量比0.96。北海康成-B今日主力资金净流入63.8万元,连续4日净流入,上一交易日主力净流入113.5万元。该股近5个交易日上涨11.82%,主力资金累计净流入240.1万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流入44.2万元,其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162046a46e0765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162046a46e0765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2592221009","title":"北海康成-B盘中异动 早盘股价大跌5.34%报1.950港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592221009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592221009?lang=zh_cn&edition=full","pubTime":"2025-12-18 10:56","pubTimestamp":1766026577,"startTime":"0","endTime":"0","summary":"2025年12月18日早盘10时56分,北海康成-B股票出现异动,股价大幅下跌5.34%。截至发稿,该股报1.950港元/股,成交量36万股,换手率0.07%,振幅3.88%。资金方面,该股资金流入12.173万港元,流出55.877万港元。北海康成-B股票所在的生物技术行业中,整体涨幅为0.52%。北海康成-B公司简介:CANbridge Pharmaceuticals Inc是一家全球生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218105618953b6928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218105618953b6928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01228","BK1161"],"gpt_icon":0},{"id":"2592969294","title":"北海康成-B12月16日主力净流出31万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592969294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592969294?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:16","pubTimestamp":1765872966,"startTime":"0","endTime":"0","summary":"12月16日, 北海康成-B股价跌3.33%,报收2.03元,成交金额182.7万元,换手率0.18%,振幅4.29%,量比0.99。北海康成-B今日主力资金净流出31万元,上一交易日主力净流出0万元。该股近5个交易日下跌6.88%,主力资金累计净流出31万元;近20日主力资金累计净流出135.0万元,其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162352a45192b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162352a45192b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0},{"id":"2589318573","title":"北海康成-B(01228)自主研发生产的CAN 103获纳入中国第一版“商保创新药目录”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589318573","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589318573?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:13","pubTimestamp":1765188831,"startTime":"0","endTime":"0","summary":"智通财经APP讯,北海康成-B 公布,该集团的国内首个本土自主研发生产的酶替代疗法一类创新药CAN 103已成功纳入中国第一版“商保创新药目录”,该目录于2026年1月1日起正式实施。CAN 103于2025年5月13日获批上市,是中国首个本土自主研发生产适用于12岁及以上青少年和成人 I型和Ⅲ型戈谢病患者的长期酶替代疗法,亦为中国首个通过生物制品分段生产检查的创新生物药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4526","BK4595","BK1161","BK4170","BK4600","BK1574","01228"],"gpt_icon":0},{"id":"2590271363","title":"北海康成-B12月08日主力净流出147.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590271363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590271363?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181745,"startTime":"0","endTime":"0","summary":"12月08日, 北海康成-B股价跌2.95%,报收2.30元,成交金额563.2万元,换手率0.48%,振幅11.81%,量比1.22。北海康成-B今日主力资金净流出147.7万元,上一交易日主力净流出0万元。该股近5个交易日上涨9.05%,主力资金累计净流出149.9万元;近20日主力资金累计净流出69.3万元,其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816193697960bae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120816193697960bae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01228"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssitimber.com.hk","stockEarnings":[{"period":"1week","weight":0.1115},{"period":"1month","weight":0.3673},{"period":"3month","weight":0.7072},{"period":"6month","weight":1.2889},{"period":"1year","weight":21.7206},{"period":"ytd","weight":0.207}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"CANbridge Pharmaceuticals Inc是一家全球生物制药公司。该公司专注于罕见病转化疗法的研究、开发和商业化。该公司拥有一个药物组合,其中包括三种获批药物和八种资产的管线,针对尚未满足需求的罕见病适应症。这些包括亨特综合征和其他溶酶体贮积症、阵发性睡眠性血红蛋白尿和其他补体介导的疾病、血友病A、代谢性疾病、罕见胆汁淤积性肝病和神经肌肉疾病。其管线包括Hunterase、Livmarli、CAN106和CAN103。Hunterase是一种酶替代疗法,用于治疗II型粘多糖贮积症(MPS II),也称为亨特综合征。Livmarli是一种口服、吸收率极低、可逆性的回肠胆汁酸转运蛋白抑制剂,正在开发中,用于治疗罕见的胆汁淤积性肝病,包括Alagille综合征和进行性家族性肝内胆汁淤积症。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.126185},{"month":2,"riseRate":0.4,"avgChangeRate":0.023405},{"month":3,"riseRate":0.25,"avgChangeRate":-0.105397},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006446},{"month":5,"riseRate":0,"avgChangeRate":-0.117685},{"month":6,"riseRate":0.25,"avgChangeRate":0.256405},{"month":7,"riseRate":0.5,"avgChangeRate":0.547002},{"month":8,"riseRate":0.25,"avgChangeRate":0.239858},{"month":9,"riseRate":0.75,"avgChangeRate":0.161514},{"month":10,"riseRate":0,"avgChangeRate":-0.161874},{"month":11,"riseRate":0.25,"avgChangeRate":-0.205763},{"month":12,"riseRate":0.5,"avgChangeRate":0.059277}],"exchange":"SEHK","name":"北海康成-B","nameEN":"CANBRIDGE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"北海康成-B,01228,北海康成-B股票,北海康成-B股票老虎,北海康成-B股票老虎国际,北海康成-B行情,北海康成-B股票行情,北海康成-B股价,北海康成-B股市,北海康成-B股票价格,北海康成-B股票交易,北海康成-B股票购买,北海康成-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"北海康成-B(01228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供北海康成-B(01228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}